Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Interest & Investment Income (2016 - 2021)

Palisade Bio (PALI) has disclosed Interest & Investment Income for 12 consecutive years, with $3917.0 as the latest value for Q1 2021.

  • On a quarterly basis, Interest & Investment Income fell 70.52% to $3917.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $24160.0, a 53.56% decrease, with the full-year FY2020 number at $33532.0, down 50.49% from a year prior.
  • Interest & Investment Income was $3917.0 for Q1 2021 at Palisade Bio, down from $5597.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $29000.0 in Q1 2019 to a low of $3917.0 in Q1 2021.
  • A 5-year average of $14954.6 and a median of $15234.0 in 2019 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: skyrocketed 87.53% in 2017, then crashed 70.52% in 2021.
  • Palisade Bio's Interest & Investment Income stood at $17274.0 in 2017, then surged by 38.35% to $23898.0 in 2018, then tumbled by 47.09% to $12645.0 in 2019, then crashed by 55.74% to $5597.0 in 2020, then tumbled by 30.02% to $3917.0 in 2021.
  • Per Business Quant, the three most recent readings for PALI's Interest & Investment Income are $3917.0 (Q1 2021), $5597.0 (Q4 2020), and $7731.0 (Q3 2020).